Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.03 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |